Volume 6 Issue 9, Sep 2021

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 6 Issue 9, Sep 2021:
Research Highlight
Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs
Zhihui Zhang,Nan Sun &Jie He  ORCID: orcid.org/0000-0002-0285-5403